These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2506626)

  • 41. Evaluating the benefits of increasing measles immunization rates.
    Zwanziger J; Szilagyi PG; Kaul P
    Health Serv Res; 2001 Oct; 36(5):885-909. PubMed ID: 11666109
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Estimating transmission intensity for a measles epidemic in Niamey, Niger: lessons for intervention.
    Grais RF; Ferrari MJ; Dubray C; Bjørnstad ON; Grenfell BT; Djibo A; Fermon F; Guerin PJ
    Trans R Soc Trop Med Hyg; 2006 Sep; 100(9):867-73. PubMed ID: 16540134
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interruption of indigenous measles transmission in Bolivia since October 2000.
    Quiroga R; Barrezueta O; Venczel L; Halkyer P; Gil F; Machicao E; Landaverde M; Quiñonez A; Izurieta H
    J Infect Dis; 2003 May; 187 Suppl 1():S121-6. PubMed ID: 12721902
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Measles vaccination: new strategies and formulations.
    de Vries RD; Stittelaar KJ; Osterhaus AD; de Swart RL
    Expert Rev Vaccines; 2008 Oct; 7(8):1215-23. PubMed ID: 18844595
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Edmonston-Zagreb strain of measles vaccine: epidemiologic evaluation in Yugoslavia.
    Ikić DM
    Rev Infect Dis; 1983; 5(3):558-63. PubMed ID: 6879014
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of protection afforded by single measles vaccination and late revaccination schedules.
    Marufu T; Siziya S; Tshimanga M; Murugasampillay S; Mason E
    East Afr Med J; 1997 Dec; 74(12):777-9. PubMed ID: 9557421
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A limited measles outbreak in a highly vaccinated US boarding school.
    Yeung LF; Lurie P; Dayan G; Eduardo E; Britz PH; Redd SB; Papania MJ; Seward JF
    Pediatrics; 2005 Dec; 116(6):1287-91. PubMed ID: 16322148
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of mass measles campaigns among children less than 5 years old in Uganda.
    Nanyunja M; Lewis RF; Makumbi I; Seruyange R; Kabwongera E; Mugyenyi P; Talisuna A
    J Infect Dis; 2003 May; 187 Suppl 1():S63-8. PubMed ID: 12721893
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cost effectiveness of prevaccination screening of health care workers for immunity to measles, rubella and mumps.
    Ferson MJ; Robertson PW; Whybin LR
    Med J Aust; 1994 Apr; 160(8):478-82. PubMed ID: 8170422
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The evolution of measles morbidity and mortality in Romania after the introduction of antimeasles vaccination].
    Cazacu E; Bălan A; Dinică V
    Bacteriol Virusol Parazitol Epidemiol; 1994; 39(1-2):35-44. PubMed ID: 7981527
    [No Abstract]   [Full Text] [Related]  

  • 51. Study of incidence of measles and vaccination coverage in Ahmedabad urban slums.
    Bhagyalaxmi A; Kedia G; Rawal VS
    Indian J Public Health; 2007; 51(1):52-3. PubMed ID: 18232144
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Progress in the control of measles in Ghana, 1980-2000.
    Bosu WK; Essel-Ahun M; Adjei S; Strebel P
    J Infect Dis; 2003 May; 187 Suppl 1():S44-50. PubMed ID: 12721890
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Progress in measles and rubella elimination in Iran.
    Esteghamati A; Gouya MM; Zahraei SM; Dadras MN; Rashidi A; Mahoney F
    Pediatr Infect Dis J; 2007 Dec; 26(12):1137-41. PubMed ID: 18043452
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of nationwide measles vaccination campaign among children aged 9 months to 14 years, Zimbabwe, 1998-2001.
    Munyoro MN; Kufa E; Biellik R; Pazvakavambwa IE; Cairns KL
    J Infect Dis; 2003 May; 187 Suppl 1():S91-6. PubMed ID: 12721898
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Measles vaccination coverage during poliomyelitis national immunization days in Burkina Faso, 1999.
    Yaméogo KR; Yaméogo A; Nacoulma SD; Zuber PL
    J Infect Dis; 2003 May; 187 Suppl 1():S74-9. PubMed ID: 12721895
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Survey of measles vaccine coverage in Brazzaville].
    Bolanda D; Talani P; Nzaba P; Moudzeo H; Biahoua M; Mayanda H; Yala F
    Bull Soc Pathol Exot; 2000 Apr; 93(2):123-4. PubMed ID: 10863618
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Measles epidemic in the Netherlands, 1999-2000.
    van den Hof S; Conyn-van Spaendonck MA; van Steenbergen JE
    J Infect Dis; 2002 Nov; 186(10):1483-6. PubMed ID: 12404165
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The economic disease burden of measles in Japan and a benefit cost analysis of vaccination, a retrospective study.
    Takahashi K; Ohkusa Y; Kim JY
    BMC Health Serv Res; 2011 Oct; 11():254. PubMed ID: 21978107
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Details of measles vaccine and vaccination].
    Duca M
    Rev Med Chir Soc Med Nat Iasi; 1986; 90(2):399-400. PubMed ID: 3764219
    [No Abstract]   [Full Text] [Related]  

  • 60. [Measles before vaccination. Statistical consideration on cases of measles hospitalized at the Clinical Hospital of Infectious Diseases in Jassy 1947-1977].
    Brauner E; Rugină V; Blindu P; Mihul V; Airinii F
    Rev Med Chir Soc Med Nat Iasi; 1980; 84(2):251-6. PubMed ID: 7221283
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.